Sec Form 4/A Filing - Bacterial Robotics, LLC @ TAURIGA SCIENCES, INC. - 2014-07-16

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4/A
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Bacterial Robotics, LLC
2. Issuer Name and Ticker or Trading Symbol
TAURIGA SCIENCES, INC. [ TAUG]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
PO BOX 30085
3. Date of Earliest Transaction (MM/DD/YY)
07/16/2014
(Street)
CINCINNATI, OH45230
4. If Amendment, Date Original Filed (MM/DD/YY)
07/22/2014
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/16/2014 S 3,500,000 D $ 0.0419 1,000 ( 1 ) D
Common Stock 15,645,009 ( 2 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owne r Name / Address Relationships
Director 10% Owner Officer Other
Bacterial Robotics, LLC
PO BOX 30085
CINCINNATI, OH45230
X
Barkeloo Jason Eric
PO BOX 30085
CINCINNATI, OH45230
X
Signatures
/s/ Jason E. Barkeloo, Chief Executive Officer of Bacterial Robotics, LLC 08/12/2014
Signature of Reporting Person Date
/s/ Jason E. Barkeloo 08/12/2014
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The shares of common stock are owned directly by Jason E. Barkeloo ("Mr. Barkeloo"), a reporting person hereunder.
( 2 )The shares of common stock are owned directly by Bacterial Robotics, LLC ("Bacterial Robotics"). As managing member and Chief Executive Officer of Bacterial Robotics and by virtue of the Voting Agreement, dated January 28, 2014, by and among the Company and members of Pilus Energy (the "Voting Agreement"), as disclosed in the reporting persons' Schedule 13D/A filed with the Securities and Exchange Commission on July 21, 2014, Mr. Barkeloo may be deemed to beneficially own the shares of common stock held by Bacterial Robotics.

Remarks:
EXPLANATORY NOTE: This amended Form 4 is being filed to add Mr. Barkeloo as a reporting person hereunder.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.